Latest Content

Anne Beal, MD, MPH Joins Omada Health Board of Directors

Dr. Beal brings extensive experience in clinical innovation, patient advocacy, and population health to Omada’s Board.

Read Article

Omada Health GLP-1 Care Track

The Problem with BMI: Addressing Inequities in Obesity Screening

With its checkered past and at times questioned clinical merits, BMI’s ubiquity in modern healthcare should be carefully considered.

Read Resource

2 months ago

New GLP-1 Indications: What you need to know

This insightful webinar delves into the expanding role of GLP-1 medications in treating a wide range of chronic conditions beyond diabetes and obesity.

Watch Video

Omada Health adds Sachin Jain, M.D., MBA, Julie Klapstein and Adam Stavisky to Board of Directors

New board members provide deep clinical and commercial experience.

Read Article

3 months ago

Omada Health’s Guide to GLP-1s | Q3 - Q4 2024

Omada drills into emerging details of the GLP-1 experience, including compounded GLP-1s, how to manage the drug’s impact on body composition, & ways to assess the value of virtual companion programs.

Read Article

4 months ago

Using AI to Strengthen Human Relationships: Q&A with Terry Miller, VP of Machine Learning, AI and Data Science Strategy

Q&A with Terry Miller, VP of Machine Learning, AI and Data Science Strategy

Read Article

4 months ago

Economic Savings Model for Omada’s Cardiometabolic Programs

Read Article

4 months ago

Omada Joins Pledge to White House-Supported Healthcare AI Commitments

Company pledges to keep humans at the center of care.

Read Article

4 months ago

Omada Health's Journey with Artificial Intelligence

How Data Science and AI learnings surprised us, taught us, and propelled us forward.

Read Article

7 months ago

Life With GLP-1s

Clinical and cultural conversations around obesity have long revolved around BMI (and its credibility), harmful stereotypes, issues of equity and the multi-million dollar weight loss industry.

Read Resource

8 months ago

How to Combat Muscle Loss While Taking GLP-1s

A side-effect of taking GLP-1s is a loss of muscle mass. Julie Mulcahy, PT, DPT, CAPP OB explores how to combat this with resistance exercises.

Read Article

7 months ago

New Research Shows Long-Term A1C Reduction and Sustained Weight Maintenance for Members in Omada Health’s Type 2 Diabetes Program

Omada Health, the virtual-first healthcare provider, published its 28th peer-reviewed study demonstrating the long-term outcomes of utilizing a behavior change program for members with type 2 diabetes

Read Article

9 months ago

The Science Behind Dieting, and Why it Doesn’t Work

Lisa McCormick, FNP-BC, RD, CDCES explores the science behind dieting and why it doesn't work. Find out more about sustainable weight loss!

Read Article

7 months ago

New Data Published by Omada Health Demonstrates the Impact of Coupling GLP-1s and Behavior Change Programming

Findings show that meaningfully engaged Omada members on GLP-1s achieved an average of 1.7 times greater weight loss, and inform a new collaboration with Evernorth's EncircleRx program.

Read Article